132 related articles for article (PubMed ID: 2812152)
1. Study of differentiation of fresh human leukemic cells by low dose cytosine arabinoside (LD Ara-C) and 12-O-tetradecanoylphorbol-13-acetate (TPA).
Kuliczkowski K; Noworolska A; Frydecka I; Sedek K; Harłozińska A
Neoplasma; 1989; 36(5):589-97. PubMed ID: 2812152
[TBL] [Abstract][Full Text] [Related]
2. Terminal differentiation of human leukemic blasts in response to 12-0-tetradecanoyl-13-phorbol acetate (TPA).
Joshi KS; Rao SG; Joshi DS; Advani SH; Bhisey AN
Anticancer Res; 1988; 8(6):1367-71. PubMed ID: 3218970
[TBL] [Abstract][Full Text] [Related]
3. [Retinoic acid and 12-0-tetradecanoylphorbol-13-acetate (TPA) inducing bipotent differentiation of cultured primary bone marrow cells from leukemia patients].
Chen ZX; Wu WL
Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):26-9. PubMed ID: 1889336
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of myeloid cells in liquid culture: 2. Acute myelocytic leukemia cells.
Archimbaud E; Preisler HD
Cell Biochem Funct; 1987 Jul; 5(3):157-66. PubMed ID: 3475187
[TBL] [Abstract][Full Text] [Related]
5. Heterogenous response of primary cultured bone marrow cells of patients with different varieties of leukemia to differentiation inducers.
Chen ZX; Wang W; Wu WL
Chin Med J (Engl); 1989 Mar; 102(3):174-82. PubMed ID: 2503303
[TBL] [Abstract][Full Text] [Related]
6. Effects of 12-O-tetradecanoylphorbol-13-acetate on the proliferation and differentiation of normal and leukemic myeloid progenitor cells.
Ozawa K; Miura Y; Hashimoto Y; Kimura Y; Urabe A; Takaku F
Cancer Res; 1983 May; 43(5):2306-10. PubMed ID: 6831455
[TBL] [Abstract][Full Text] [Related]
7. Influence of small doses cytosine arabinoside (Ara-C) on leukemic cells in vitro and in vivo. Results in patients with leukemia and myelodysplastic syndrome.
Kuliczkowski K; Kotlerek-Haus S; Frydecka I; Sedek K; Nowicka J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):738-48. PubMed ID: 2436986
[TBL] [Abstract][Full Text] [Related]
8. Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside.
Yang GS; Wang C; Minkin S; Minden MD; McCulloch EA
J Cell Physiol; 1991 Jul; 148(1):60-7. PubMed ID: 1860896
[TBL] [Abstract][Full Text] [Related]
9. [Effect of cytosine arabinoside on the differentiation of granulocyte-monocyte progenitors (CFU-GM) and myeloid leukemia blasts (CFU-L) in vitro].
Wächter M; Goldschmidt H; Blau W; Elstner E; Ihle R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):927-34. PubMed ID: 2467864
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the lethal effects in culture of cytosine arabinoside and arabinofuranosyl-5-azacytosine acting on the blast cells fo acute myeloblastic leukemia.
Yang GS; McCulloch EA
Hematol Pathol; 1992; 6(3):125-30. PubMed ID: 1385380
[TBL] [Abstract][Full Text] [Related]
11. Preferential growth inhibition of human leukemic versus normal myeloid colony-forming cells by 12-O-tetradecanoylphorbol-13-acetate.
Park CH
Exp Hematol; 1984 Jun; 12(5):285-90. PubMed ID: 6723821
[TBL] [Abstract][Full Text] [Related]
12. Effect of cytosine arabinoside on differentiation of normal human bone marrow cells.
Nagler A; Kletter Y; Ricklis I; Gazit E; Tatarsky I; Fabian I
Exp Hematol; 1986 Mar; 14(3):241-5. PubMed ID: 2419152
[TBL] [Abstract][Full Text] [Related]
13. [Differentiation induction of myeloid leukemia cells by glucocorticoid--the differentiation induction effect in vitro and in vivo].
Nakamaki T; Sakashita A; Sano M; Hino K; Suzuki K; Tomoyasu S; Tsuruoka N
Rinsho Ketsueki; 1989 Feb; 30(2):149-57. PubMed ID: 2746870
[TBL] [Abstract][Full Text] [Related]
14. Growth modulation and differentiation of acute myeloid leukemia cells by jaspamide.
Fabian I; Shur I; Bleiberg I; Rudi A; Kashman Y; Lishner M
Exp Hematol; 1995 Jul; 23(7):583-7. PubMed ID: 7601248
[TBL] [Abstract][Full Text] [Related]
15. Intracellular retention of cytosine arabinoside triphosphate in blast cells from children with acute myelogenous and lymphoblastic leukemia.
Boos J; Hohenlöchter B; Schulze-Westhoff P; Schiller M; Zimmermann M; Creutzig U; Ritter J; Jurgens H
Med Pediatr Oncol; 1996 Jun; 26(6):397-404. PubMed ID: 8614376
[TBL] [Abstract][Full Text] [Related]
16. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
Stöckbauer P; Malasková V; Soucek J; Chudomel V
Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of phorbol esters on normal myeloid precursors and leukemic cells: basis for autologous bone marrow reconstitution in acute nonlymphocytic leukemia using phorbol ester-treated bone marrow from patients in remission.
Abrahm JL; Gerson SL; Hoxie JA; Tannenbaum SH; Cassileth PA; Cooper RA
Cancer Res; 1986 Jul; 46(7):3711-6. PubMed ID: 3518922
[TBL] [Abstract][Full Text] [Related]
19. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
